-
Something wrong with this record ?
Inhibition of F1 -ATPase from Trypanosoma brucei by its regulatory protein inhibitor TbIF1
O. Gahura, B. Panicucci, H. Váchová, JE. Walker, A. Zíková,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
MC_U105663150
Medical Research Council - United Kingdom
MC_EX_MR/M009858/1
Medical Research Council - United Kingdom
NLK
Free Medical Journals
from 2005 to 1 year ago
Medline Complete (EBSCOhost)
from 2005-01-01 to 1 year ago
Wiley Free Content
from 2005 to 1 year ago
PubMed
30288927
DOI
10.1111/febs.14672
Knihovny.cz E-resources
- MeSH
- Enzyme Inhibitors chemistry pharmacology MeSH
- Mutation MeSH
- Proteins chemistry genetics pharmacology MeSH
- Proton-Translocating ATPases antagonists & inhibitors MeSH
- Gene Expression Regulation * MeSH
- Amino Acid Sequence MeSH
- Sequence Homology MeSH
- Cattle MeSH
- Trypanosoma brucei brucei enzymology MeSH
- Animals MeSH
- Check Tag
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Hydrolysis of ATP by the mitochondrial F-ATPase is inhibited by a protein called IF1 . In the parasitic flagellate, Trypanosoma brucei, this protein, known as TbIF1 , is expressed exclusively in the procyclic stage, where the F-ATPase is synthesizing ATP. In the bloodstream stage, where TbIF1 is absent, the F-ATPase hydrolyzes ATP made by glycolysis and compensates for the absence of a proton pumping respiratory chain by translocating protons into the intermembrane space, thereby maintaining the essential mitochondrial membrane potential. We have defined regions and amino acid residues of TbIF1 that are required for its inhibitory activity by analyzing the binding of several modified recombinant inhibitors to F1 -ATPase isolated from the procyclic stage of T. brucei. Kinetic measurements revealed that the C-terminal portion of TbIF1 facilitates homodimerization, but it is not required for the inhibitory activity, similar to the bovine and yeast orthologs. However, in contrast to bovine IF1 , the inhibitory capacity of the C-terminally truncated TbIF1 diminishes with decreasing pH, similar to full length TbIF1 . This effect does not involve the dimerization of active dimers to form inactive tetramers. Over a wide pH range, the full length and C-terminally truncated TbIF1 form dimers and monomers, respectively. TbIF1 has no effect on bovine F1 -ATPase, and this difference in the mechanism of regulation of the F-ATPase between the host and the parasite could be exploited in the design of drugs to combat human and animal African trypanosomiases.
Institute of Parasitology Biology Centre Czech Academy of Science České Budějovice Czech Republic
The Medical Research Council Mitochondrial Biology Unit University of Cambridge UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028170
- 003
- CZ-PrNML
- 005
- 20190819095918.0
- 007
- ta
- 008
- 190813s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/febs.14672 $2 doi
- 035 __
- $a (PubMed)30288927
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Gahura, Ondřej $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic. The Medical Research Council Mitochondrial Biology Unit, University of Cambridge, UK.
- 245 10
- $a Inhibition of F1 -ATPase from Trypanosoma brucei by its regulatory protein inhibitor TbIF1 / $c O. Gahura, B. Panicucci, H. Váchová, JE. Walker, A. Zíková,
- 520 9_
- $a Hydrolysis of ATP by the mitochondrial F-ATPase is inhibited by a protein called IF1 . In the parasitic flagellate, Trypanosoma brucei, this protein, known as TbIF1 , is expressed exclusively in the procyclic stage, where the F-ATPase is synthesizing ATP. In the bloodstream stage, where TbIF1 is absent, the F-ATPase hydrolyzes ATP made by glycolysis and compensates for the absence of a proton pumping respiratory chain by translocating protons into the intermembrane space, thereby maintaining the essential mitochondrial membrane potential. We have defined regions and amino acid residues of TbIF1 that are required for its inhibitory activity by analyzing the binding of several modified recombinant inhibitors to F1 -ATPase isolated from the procyclic stage of T. brucei. Kinetic measurements revealed that the C-terminal portion of TbIF1 facilitates homodimerization, but it is not required for the inhibitory activity, similar to the bovine and yeast orthologs. However, in contrast to bovine IF1 , the inhibitory capacity of the C-terminally truncated TbIF1 diminishes with decreasing pH, similar to full length TbIF1 . This effect does not involve the dimerization of active dimers to form inactive tetramers. Over a wide pH range, the full length and C-terminally truncated TbIF1 form dimers and monomers, respectively. TbIF1 has no effect on bovine F1 -ATPase, and this difference in the mechanism of regulation of the F-ATPase between the host and the parasite could be exploited in the design of drugs to combat human and animal African trypanosomiases.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a inhibitory enzymů $x chemie $x farmakologie $7 D004791
- 650 12
- $a regulace genové exprese $7 D005786
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a proteiny $x chemie $x genetika $x farmakologie $7 D011506
- 650 _2
- $a protonové ATPasy $x antagonisté a inhibitory $7 D006180
- 650 _2
- $a sekvenční homologie $7 D017385
- 650 _2
- $a Trypanosoma brucei brucei $x enzymologie $7 D014346
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Panicucci, Brian $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic.
- 700 1_
- $a Váchová, Hana $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic.
- 700 1_
- $a Walker, John E $u The Medical Research Council Mitochondrial Biology Unit, University of Cambridge, UK.
- 700 1_
- $a Zíková, Alena $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic. Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
- 773 0_
- $w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 285, č. 23 (2018), s. 4413-4423
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30288927 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190819100152 $b ABA008
- 999 __
- $a ok $b bmc $g 1433319 $s 1066630
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 285 $c 23 $d 4413-4423 $e 20181017 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
- GRA __
- $a MC_U105663150 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_EX_MR/M009858/1 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20190813